Effects of N-acetylcysteine on spexin immunoreactivity in kidney tissues of rats treated with adriamycin

dc.contributor.authorYalcin, Tuba
dc.contributor.authorKuloglu, Tuncay
dc.contributor.authorTektemur, Nalan Kaya
dc.contributor.authorTektemur, Ahmet
dc.contributor.authorOzan, Ibrahim Enver
dc.date.accessioned2026-08-12T17:38:36Z
dc.date.issued2024
dc.departmentFırat Üniversitesi
dc.description.abstractObjective(s): Due to its negative side effects, mainly nephrotoxicity, adriamycin (ADR) is used fairly infrequently. The purpose of this study is to investigate the effects of N-acetyl cysteine (NAC) on the immunoreactivity of spexin (SPX) in the kidney tissues of rats given ADR. Materials and Methods: A total of 28 male Sprague-Dawley rats were randomly assigned to four groups (n=7): control (no intervention), NAC (150 mg/kg/day, administered intraperitoneally), ADR (single dose of 15 mg/kg, administered intraperitoneally), and ADR+NAC (single dose of 15 mg/kg ADR + 150 mg/kg/day NAC, both administered intraperitoneally). The experiment was concluded on the 15th day. Results: The administration of ADR resulted in biochemical and histopathological alterations in the kidney. It was found that ADR treatment led to elevated levels of TOS (total oxidative stress), apoptosis, and SPX. Conversely, when NAC was administered as a treatment, it effectively reduced TOS, apoptosis, and SPX levels. These findings suggest that SPX may contribute to the development of ADR-induced kidney damage. Conclusion: Further investigations are warranted to gain a comprehensive understanding of kidney damage, and specifically to elucidate the role of SPX in this context. Additionally, these studies can pave the way for exploring novel therapeutic strategies targeting SPX to prevent and/or treat the development of kidney damage.
dc.description.sponsorshipFirat University Scientific Research Projects, Turkey [21.11]
dc.description.sponsorshipFunding This study received support from Firat University Scientific Research Projects, Turkey (Project Number TF. 21.11) .
dc.identifier.doi10.22038/IJBMS.2023.71942.15635
dc.identifier.endpage240
dc.identifier.issn2008-3866
dc.identifier.issn2008-3874
dc.identifier.issue2
dc.identifier.pmid38234666
dc.identifier.scopus2-s2.0-85181091717
dc.identifier.scopusqualityQ2
dc.identifier.startpage233
dc.identifier.urihttps://doi.org/10.22038/IJBMS.2023.71942.15635
dc.identifier.urihttps://hdl.handle.net/11508/58509
dc.identifier.volume27
dc.identifier.wosWOS:001134927800003
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMashhad Univ Med Sciences
dc.relation.ispartofIranian Journal of Basic Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectAdriamycin N-Acetylcysteine Nephrotoxicity Neuropeptide Q Spexin
dc.titleEffects of N-acetylcysteine on spexin immunoreactivity in kidney tissues of rats treated with adriamycin
dc.typeArticle

Dosyalar